Supplementary Table S4 from Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S4. Additional patient characteristics of HPV positive HNSCC patients.
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4407109415